Chardan Capital boosted the price target on Intellia Therapeutics, Inc. (NASDAQ: NTLA) from $121 to $129. Intellia Therapeutics shares fell 3% to close at $53.30 on Monday.
The CNN Money Fear and Greed index showed some easing in the overall market sentiment as US stocks dropped to start the week.
The S&P 500 jumped around 5.9% last week, recording its best weekly surge since June.
US stocks closed lower on Monday, as investors digested recent comments from the Federal Reserve officials.
The S&P 500, during the previous week, recorded its biggest weekly percentage surge since late June.
U.S. stocks closed lower on Monday, with the Dow Jones dropping more than 200 points. Here is the list of some big stocks recording gains in the previous session.
BMO Capital boosted the price target on MacroGenics, Inc. (NASDAQ: MGNX) from $5.7 to $16. BMO Capital analyst Etzer Darout upgraded the stock from Market Perform to Outperform. MacroGenics shares gained 3.5% to trade at $6.97 on Monday.
U.S. stocks closed higher on Friday, with the Nasdaq Composite jumping more than 200 points. Here is the list of some big stocks recording gains in the previous session.
US stocks extended gains, with the S&P 500 and Nasdaq settling sharply higher on Friday.
On Thursday, the S&P 500 and Nasdaq recorded their biggest daily percentage surge in over 2-1/2 years as annual inflation in the US dropped below the 8% mark for the first time in eight months.